Dementia

Alzheimer drug effective against vascular dementias

Published in Drug Week, November 15th, 2002

Early drug therapy for most dementia patients may be warranted, even before the type of dementia has been determined, according to a report presented at the American Neurological Association's 127th annual meeting in New York City.

In a 6-month clinical trial, researchers found that an Alzheimer disease drug was also effective in varieties of dementia that involve abnormalities in blood circulation to the brain.

"We found that cholinesterase inhibitors will benefit patients with Alzheimer's disease or vascular dementia, or mixed cases involving both Alzheimer's and vascular causes. This provides further support for treating patients with these drugs...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2002-11-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry